(19)

(11)

EP 4 268 231 A1

(12)

(43) Date of publication: 01.11.2023 Bulletin 2023/44 (21) Application number: 21920475.7 (22) Date of filing: 30.04.2021

(51) International Patent Classification (IPC):  G16B 20/30(2019.01) G16B 40/00(2019.01) G16B 30/10(2019.01) C12N 15/10(2006.01) (52) Cooperative Patent Classification (CPC): G16B 40/00; G16B 20/00; C12Q 1/6806   C-Sets: C12Q 1/6806, C12Q 2523/125, C12Q 2535/122; (86) International application number: PCT/CN2021/091761 (87) International publication number: WO 2022/156089 (28.07.2022 Gazette 2022/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 20.01.2021 CN 202110072090 21.01.2021 CN 202110078570 (71) Applicants: Genecast Biotechnology Co., Ltd Wuxi, Jiangsu 214000 (CN) Genecast (Beijing) Biotechnology Co., Ltd. Beijing 100089 (CN) Genecast (Wuxi) Precision Medicine Diagnostic Laboratory Co., Ltd. Wuxi, Jiangsu 214000 (CN)

(72) Inventors: HAN, Tiancheng Beijing 100089 (CN) SONG, Xiaofeng Beijing 100089 (CN) YU, Jianing Beijing 100089 (CN) HONG, Yuanyuan Beijing 100089 (CN) HE, Ji Beijing 100089 (CN) CHEN, Weizhi Beijing 100089 (CN) DU, Bo Beijing 100089 (CN) (74) Representative: Frick, Robert  Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB Widenmayerstraße 23 80538 München 80538 München (DE)